STAT
JUNE 2, 2023
Vince Wescott was ready for top surgery. He had the cash saved up, he’d gotten a letter from his therapist, and he’d sent in the required photos of his chest and torso in preparation for a consultation. When his surgeon’s office called unexpectedly, he picked up, assuming that they were missing paperwork or needed to reschedule.
PharmaVoice
JUNE 2, 2023
Healthcare pros share the market drivers they believe are having the biggest impact on the industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 2, 2023
I’m standing over an operating table, excising a skin cancer from the forehead of an elderly gentleman while soft piano music echoes off the floor tiles. I’ve performed this procedure thousands of times, and I always enjoy the placid focus and deep satisfaction performing cutaneous surgery brings me. All I’ve done in adulthood has brought me here: cadaver prosections in anatomy labs, mentorship from dermatologic surgeons , and mastering various knot-tying techniq
PhRMA
JUNE 2, 2023
With Congress discussing policy changes that would lower drug costs for patients and rein in powerful middlemen, insurers and their PBMs are dusting off their old playbook and once again threatening to increase costs for employers if required to do their job and actually provide meaningful coverage to patients. But recent remarks by one executive make clear that the PBM industry has a choice: protect its profits or lower costs for patients.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JUNE 2, 2023
Several years ago, a local artist asked if she could paint my younger daughter, then a tween, as part of a series of life-size portraits of people she knew. Monica Aissa Martinez really gets under her subjects’ skin — the final product is more medical map than pretty picture, documenting the elements (both scientific and ephemeral) that make a person unique.
BioPharma Dive
JUNE 2, 2023
Treatment with Kisqali reduced the risk of disease recurrence when used after surgery, potentially positioning Novartis to win a similar adjuvant approval as Lilly’s rival therapy Verzenio.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
JUNE 2, 2023
The final draft guidance recommends rimegepant for adults who have at least four migraine attacks per month, but less than 15 - News - PharmaTimes
STAT
JUNE 2, 2023
Kisqali, a breast cancer pill made by Novartis, reduced the risk of recurrence of the most common type of early breast cancer by 25% in a key trial, researchers said Friday. The findings will likely lead to regulatory approvals and broader use of the medicine, which could represent a financial windfall for Novartis. The company has forecast that the new market for the medicine could reach $3 billion.
Pharma Times
JUNE 2, 2023
BI-1910 is now the second of the company's anti-tumour necrosis factor receptor 2 programmes to enter clinical development - News - PharmaTimes
STAT
JUNE 2, 2023
WASHINGTON — President Biden plans to tap longtime federal and state health official Mandy Cohen to lead the Centers for Disease Control and Prevention after Rochelle Walensky departs at the end of June , according to three people with knowledge of his plans. If appointed, Cohen would inherit an agency in the midst of assessing its Covid-19 response, including criticisms that it stumbled on test and masking guidance and stoked Americans’ frustration with public health agencies.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
JUNE 2, 2023
The European Commission (EC) has approved TG Therapeutics’ Briumvi (ublituximab-xiiy) to treat relapsing forms of multiple sclerosis (RMS) in adult patients. Briumvi is an anti-CD20 monoclonal antibody indicated for RMS adult patients with active disease which is defined by clinical or imaging features. It has been engineered to remove certain sugar molecules generally expressed on the antibody.
STAT
JUNE 2, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. We plan to promenade with our official mascots (yes, we have taken on another, who we will introduce shortly), catch up on our reading, and, if time permits, hold a listening party.
PharmaTech
JUNE 2, 2023
An increase in applications for gene therapies is putting stress on FDA’s resources.
STAT
JUNE 2, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. However, we are interrupting our usual programming to note that we will return with a featured person next week.
The Pharmacist
JUNE 2, 2023
Reduced hours for late night pharmacies could put elderly, vulnerable and end-of-life patients at risk, clinicians have warned. Regulatory changes came into force last week which allowed pharmacies on 100-hour contracts to reduce their total weekly core opening hours to no less than 72 hours, including the option to close at 9pm rather than 11pm. […] The post Concerns 100-hour pharmacy easements could risk out-of-hours access appeared first on The Pharmacist.
Putting Patients First Blog
JUNE 2, 2023
Washington Representatives Summer Meeting Event Time: 12:00 - 6:00 p.m. ET Event Location: Top of the Hill Banquet & Conference Center, Washington DC The Washington Representatives Summer Meeting will bring together leading government relations and policy professionals from the NHC’s member patient advocacy and other health nonprofit organizations.
European Pharmaceutical Review
JUNE 2, 2023
A novel refractometry-based process analytical technology (PAT) system used to monitor HEK293T cell cultures during lentiviral vector (LVV) production in real time, was able rapidly identify a relationship between bioreactor pH and culture metabolic activity, a paper has found. Using PAT in the biotechnology and biopharmaceutical industries is a radical vision” Williams et al. stated that to their knowledge, the study represents the first time that pH has been incorporated into a metabolic
PharmaTech
JUNE 2, 2023
Manufacturers must figure out how flexible they need to be to meet the numerous new requirements of the changing therapeutic and regulatory landscapes.
European Pharmaceutical Review
JUNE 2, 2023
The Centre for Process Innovation (CPI) is set to establish a new UK Intracellular Drug Delivery Centre to develop new lipid nanoparticle (LNP) formulations for RNA medicine delivery, and a framework to advance next-generation nano delivery systems. Under the first-of-its-kind partnership in the UK, CPI will work with the Medicines Discovery Catapult, the University of Strathclyde, the University of Liverpool and Imperial College London using a £10 million, three-year grant funded by Innovate UK
Express Pharma
JUNE 2, 2023
The proliferation of falsified drugs and counterfeit medicines globally has become a pressing concern, significantly impacting patient safety. Incidences of these fraudulent products have posed grave threats to individuals relying on medications for their well-being. Counterfeit drugs, intentionally mislabeled or misrepresented, often contain substandard or harmful ingredients, incorrect dosages, or no active ingredients at all.
World Pharma News
JUNE 2, 2023
Insilico Medicine ("Insilico"), a generative artificial intelligence (AI)-driven clinical stage drug discovery company, announced that the U.S. Food and Drug Administration (FDA) recently approved the initial investigational new drug (IND) application for ISM3091 for the treatment of patients with solid tumors. This is Insilico's first oncology program to advance to the clinical validation stage.
European Pharmaceutical Review
JUNE 2, 2023
Following its announced separation from Novartis in August 2022, Sandoz AG has declared plans to move its headquarters to Basel, Switzerland in mid-2024. With 2022 data by the Swiss federal government establishing that the trend for biotech companies to headquarter in Switzerland is continuing, Sandoz CEO Richard Saynor offered more evidence for this preference: “Basel is a global centre for the life sciences industry, attracting an unrivalled pool of talent and experience” Isma Hachi, D
PharmaTech
JUNE 2, 2023
Using the four-phased method to assess QRM can ensure continual improvement and that regulatory requirements are met.
assurecare
JUNE 2, 2023
Utilization management has traditionally aimed to optimize resource utilization and control healthcare costs through reviewing and approving or denying requests for medical services. However, the evolving healthcare landscape recognizes the need for a transformative approach to utilization management software that prioritizes whole-person care. This approach acknowledges that individuals are more than just their physical ailments and puts emphasis on their mental, emotional, and social well-bein
PharmaTech
JUNE 2, 2023
Nanotech-based delivery technologies are receiving significant attention.
The Pharmacist
JUNE 2, 2023
Negotiating body Community Pharmacy Scotland (CPS) has said that an additional £20m for the Scottish drug tariff announced this week is not enough to cover community pharmacy’s increased medicines bill. On Wednesday (31 May), CPS announced that the community pharmacy sector in Scotland would receive an extra £20m over the remainder of the financial year […] The post Scotland’s £20m drug tariff uplift ‘not sufficient’, says negotiator appeared first on The Pharmacist.
BioPharma Dive
JUNE 2, 2023
A drug the company acquired from AstraZeneca and developed for gram-negative infections — a growing public health threat — could be headed for a regulatory review later this year.
Pharmaceutical Commerce
JUNE 2, 2023
The Medicare Part D cap in 2025 won’t solve patients’ need for financial assistance.
Pharmacy Times
JUNE 2, 2023
Investigators found thinner ventricular walls, disorganized and ruptured myocardial fiber, mild inflammatory infiltration, and mild epicardia or interstitial fibrosis in the hearts of mice infected with COVID-19.
pharmaphorum
JUNE 2, 2023
CMS update on Alzheimer's coverage raises questions Phil.
Drug Patent Watch
JUNE 2, 2023
Annual Drug Patent Expirations for LUPRON+DEPOT-PED+KIT Lupron Depot-ped Kit is a drug marketed by Abbvie Endocrine Inc and is included in one NDA. It is available from one supplier. The… The post New patent for Abbvie Endocrine drug LUPRON DEPOT-PED KIT appeared first on DrugPatentWatch - Make Better Decisions.
Pharma and Life Sciences Blog
JUNE 2, 2023
Microsoft Azure OpenAI Service Banner 3 Vijendra Sat, 06/03/2023 - 02:29 This integration empowers clients to gain deeper insights and improve procurement and supply chain operations Asset type Newsroom Banner Slide Title GEP Uses Microsoft Azure OpenAI Service To Enhance Its Software Mobile Banner Image Top Banner Download Link Read Now
Drug Patent Watch
JUNE 2, 2023
Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are three patents… The post New patent for Amgen Inc drug LUMAKRAS appeared first on DrugPatentWatch - Make Better Decisions.
Putting Patients First Blog
JUNE 2, 2023
Summary Released! 2023 Science of Patient Engagement Symposium: “Patient Empowerment in The Digital Health Era” June 2, 2023 By: The NHC’s Research & Program’s Team Thank you to those who joined us at the National Health Council’s (NHC’s) 2023 Science of Patient Engagement Symposium, held in person on May 8, at the historic National Press Club in Washington, DC!
PharmaTech
JUNE 2, 2023
A contamination control strategy should provide an overview of how contamination and containment practices work together to ensure product quality and patient safety, says Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates.
Expert insights. Personalized for you.
264 
Let's personalize your content